Intraperitoneal therapy for ovarian cancer: Impact on survival and recurrence--The result of multi-institutional studies

16068 Background: For optimal debulked mullerian cancer (MC), the Intraperitoneal (IP) therapy has become the effective modality of chemotherapy to obtain better prognosis. We have reported KCOG981...